Suven Life Sciences Share Price
Small Cap | Pharmaceuticals and health care | NSE: SUVEN | BSE: 530239
₹117.15 
-1.25 (-1.06 %)
Last Updated: 21 Feb 2025 04:01 PM
BEARISH
Overview
Open (₹) 118.00
High (₹) 120.90
Low (₹) 116.85
Prev. Close (₹) 118.40
Volume 5,767
VWAP (₹) 118.61
ROCE (%) -41.77
Industry P/E 61.12
TTM P/E -17.83
P/B Ratio 9.50
Market Cap (₹) Cr.2,564.55
Dividend Yield (%)--
EPS (₹) -4.82
ROE-38.93%
Sales Growth (%) -13.64
Profit Growth (%)-11.15
Day Range
120.90120.90
52 Week Range
83.27169.00
Historical Returns
Returns (6M)
-23.21 %
Returns (1Y)
10.36 %
Returns (3Y)
64.77 %
Returns (5Y)
109.68 %
Returns (6M)
-23.21 %
Returns (1Y)
10.36 %
Returns (3Y)
64.77 %
Returns (5Y)
109.68 %
SWOT Analysis
- Company with no debt
- Bullish MACD crossover (12,6,9) indicates potential upward price movement.
Technicals
Technical Rating
BEARISHRSI 39.49
MFI 49.62
ATR 7.25
Commodity Channel Index -49.00
ROC125 -22.30
ROC21 -3.05
Williams %R -61.94
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 119.95 | 122.45 | 124.00 | 118.40 | 115.90 | 114.35 | 111.85 |
| Week Ago | 123.11 | 129.98 | 134.21 | 118.88 | 112.01 | 107.78 | 100.91 |
| Month Ago | 135.64 | 140.97 | 143.99 | 132.62 | 127.29 | 124.27 | 118.94 |
EMA & SMA
117.15
Current Price
Bullish Moving Averages
2
Bearish Moving Averages
18
5 Day 115.60
9 Day 118.58
10 Day 121.28
12 Day 123.52
14 Day 123.83
20 Day 122.01
26 Day 124.21
50 Day 129.48
100 Day 130.02
200 Day 127.08
Deals & Announcements
Bulk and Block Deals
Insider Trading
| Date | Name | Action | Avg. Price | Quantity | Deal Value |
|---|---|---|---|---|---|
| 29 May, 2024 | SUDHARANI JASTI | Acquisition | ₹ | 15,25,535 | BSE |
| 29 Mar, 2022 | Jasti Property and Equity Holdings Private Limited in its capacity as sole trustee of the Jasti Family Trust | Acquisition | ₹81.57 | 1,81,00,000 | BSE |
| 06 Apr, 2021 | Jasti Property and Equity Holdings Private Limited in its capacity as sole trustee of the Jasti Family Trust | Acquisition | ₹81.57 | 1,81,00,000 | BSE |
| 02 Sept, 2020 | VENKATA RAMUDU JASTHI | Acquisition | ₹49.30286666666666666666666667 | 15,000 | BSE |
| 31 Aug, 2020 | VENKATA RAMUDU JASTHI | Acquisition | ₹53.8089 | 10,000 | BSE |
| 27 Aug, 2020 | VENKATA RAMUDU JASTHI | Acquisition | ₹52.71595 | 20,000 | BSE |
| 24 Aug, 2020 | VENKATA RAMUDU JASTHI | Acquisition | ₹50.0125 | 20,000 | BSE |
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 24 Jun, 2022 | Rights issue of equity shares of Re. 1/- in the ratio of 1:2 @ premium of Rs. 54/-. | 17 Oct, 2022 | 18 Oct, 2022 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 03 Feb, 2025 | NSE India | Report of the Monitoring Agency with respect to utilization of proceeds of the Rights Issue for the quarter ended 31st December, 2024. |
| 03 Feb, 2025 | BSE India | Report of the Monitoring Agency for quarter ended December 31, 2024 regarding utilisation of proceeds of the rights issue |
| 25 Jan, 2025 | NSE India | Suven Life Sciences Limited has informed the Exchange about Copy of Newspaper Publication |
| 24 Jan, 2025 | NSE India | Integrated Filing- Financial |
| 24 Jan, 2025 | BSE India | Please find enclosed Integrated Filing Financials for quarter ended 31 December, 2024 |
| 24 Jan, 2025 | NSE India | Suven Life Sciences Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 |
| 24 Jan, 2025 | BSE India | Statement of deviation or variation for quarter ended December 31, 2024 |
| 24 Jan, 2025 | BSE India | Unaudited standalone & consolidated financial results for quarter ended December 31, 2024 |
| 24 Jan, 2025 | NSE India | Suven Life Sciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024. |
| 16 Jan, 2025 | NSE India | SUVEN LIFE SCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 24-Jan-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2024 . |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results | -- | 17 Jan, 2025 | 24 Jan, 2025 |
| Quarterly Results | -- | 22 Oct, 2024 | 29 Oct, 2024 |
| Quarterly Results | -- | 30 Jul, 2024 | 05 Aug, 2024 |
| Audited Results | -- | 30 Apr, 2024 | 06 May, 2024 |
| Quarterly Results | -- | 24 Jan, 2024 | 30 Jan, 2024 |
| Quarterly Results | -- | 30 Oct, 2023 | 04 Nov, 2023 |
| Quarterly Results | -- | 03 Aug, 2023 | 08 Aug, 2023 |
| Audited Results | -- | 04 May, 2023 | 09 May, 2023 |
| Quarterly Results | -- | 26 Jan, 2023 | 02 Feb, 2023 |
| Quarterly Results | -- | 04 Nov, 2022 | 10 Nov, 2022 |
Share Holding Pattern
| Owner Name | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 | Sept, 2023 |
|---|
About Suven Life Sciences
Suven Life Sciences is a Public Limited Listed company incorporated on 09/03/1989 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L24110TG1989PLC009713 and registration number is 009713. Currently Company is involved in the business activities of Other professional, scientific and technical activities. Company’s Total Operating Revenue is Rs. 11.69 Cr. and Equity Capital is Rs. 21.81 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1989
Managing Director
Mr. Venkateswarlu Jasti
NSE Symbol
SUVEN
Suven Life Sciences Management
| Name | Designation |
|---|---|
| Mr. Venkateswarlu Jasti | Chairman & Managing Director |
| Mrs. Sudharani Jasti | Whole Time Director |
| Prof. Seyed E Hasnain | Director |
| Mr. Santanu Mukherjee | Director |
| Mrs. J A S Padmaja | Director |
| Dr. Vajja Sambasiva Rao | Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| Syngene Intl | ₹34,229.73 | ₹713.75  ₹714.60(-0.12%) | ₹608.000 - ₹960.000 |
| SPARC | ₹6,538.46 | ₹129.43 ₹135.25(-4.30%) | ₹189.450 - ₹474.000 |
| Suven Life | ₹2,798.32 | ₹117.60 ₹118.45(-0.72%) | ₹80.100 - ₹169.000 |
| Vimta Labs | ₹2,215.44 | ₹946.75 ₹965.65(-1.96%) | ₹400.150 - ₹1,070.550 |
| Choksi Labs | ₹45.34 | ₹129.00 ₹131.50(-1.90%) | ₹38.320 - ₹94.000 |
FAQs on Suven Life Sciences
What is the share price of Suven Life Sciences?
The share price of Suven Life Sciences on 21 Feb, 2025 is ₹ 117.15.
What is 52W high and 52W low share price of Suven Life Sciences?
The highest and lowest 52W share prices of Suven Life Sciences are ₹ 169.000 and ₹ 80.100
What is the market cap of Suven Life Sciences?
The market capitalization of Suven Life Sciences as of 21 Feb, 2025 is ₹ 2,564.55 Crores
What is the P/E ratio of Suven Life Sciences?
The current P/E ratio of Suven Life Sciences as of 21 Feb, 2025 is 61.12
What is the PB ratio of Suven Life Sciences?
The PB ratio of Suven Life Sciences as of 21 Feb, 2025 is 9.50
Top Gainers
948IHFL26I
IBHFL NCD186
₹845.00
₹705.00 (0.20%)
GREAVESCOT
Greaves
₹281.85
₹234.90 (0.20%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.20%)
CAPRO
Caprola.Chem
₹62.40
₹52.00 (0.20%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.10%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.10%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0.00%)